Loading market dashboard

Financials in USD. Standardized financial statements.
A compact view of how BG Medicine, Inc. turns revenue into operating income and net income.
| Metric | FY 2015 | FY 2014 | FY 2013 | FY 2012 | FY 2011 | FY 2010 | FY 2009 | FY 2008 | FY 2006 | FY 2005 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue? | $1.57M | $2.79M | $4.07M | $2.81M | $1.63M | $819,000 | $8.49M | $14.58M | $6.05M | $1.53M |
| Revenue Growth? | -43.8% | -31.6% | +44.7% | +72.3% | +99.5% | -90.4% | -41.8% | +141.2% | +294.6% | 0.0% |
| Cost of Revenue? | $505,000 | $956,000 | $1.39M | $957,000 | $619,000 | $786,000 | $8.43M | $13.82M | $0 | $0 |
| Gross Profit? | $1.06M | $1.83M | $2.68M | $1.86M | $1.01M | $33,000 | $59,000 | $758,000 | $6.05M | $1.53M |
| Gross Margin? | +67.8% | +65.7% | +65.9% | +66.0% | +62.1% | +4.0% | +0.7% | +5.2% | +100.0% | +100.0% |
| Operating Expenses? | $5.69M | $9.19M | $17.06M | $17.00M | $18.50M | $14.64M | $16.05M | $11.33M | $10.24M | $9.24M |
| Operating Income? | -$4.63M | -$7.36M | -$14.37M | -$22.73M | -$17.48M | -$14.61M | -$15.99M | -$10.57M | -$4.19M | -$7.70M |
| EBITDA? | -$5.06M | -$7.21M | -$14.76M | -$22.41M | -$17.07M | -$13.83M | -$15.23M | -$9.98M | -$3.54M | -$6.65M |
| Income Before Tax | -$5.30M | -$8.06M | -$15.85M | -$23.77M | -$17.52M | -$14.38M | -$16.01M | $0 | $0 | -$6.67M |
| Income Tax Expense | $0 | $0 | $0 | $0 | -$323,000 | $2.56M | $149,000 | $4.50M | $550,000 | $528,000 |
| Net Income? | -$5.30M | -$8.06M | -$15.85M | -$23.77M | -$17.58M | -$17.16M | -$16.14M | -$15.07M | -$4.74M | -$8.23M |
| EPS? | $-0.55 | $-0.99 | $-2.33 | $-4.70 | $-3.99 | $-23.10 | $-22.02 | $-20.29 | $-6.38 | $-11.08 |
| Diluted EPS? | $-0.55 | $-0.99 | $-2.33 | $-4.70 | $-3.99 | $-23.10 | $-22.02 | $-20.29 | $-6.38 | $-11.08 |
Revenue, profitability, margins, EPS, and share-count trends over time.
Top-line demand and scale over time
Profit left after direct production costs
Core business profitability before financing and tax
Bottom-line profit after all expenses
Profit allocated to each diluted share
Share count trend that affects EPS quality
Gross, operating, and net margin quality